Besides the higher CRP and lower lymphocyte count levels, GDF-15 concentrations were higher in patients with moderate to severe COVID-19 during acute infection as compared to those with mild COVID-19 and controls, and GDF-15 concentrations remained elevated at follow-up. This evidence concerns the gene GDF15 and COVID-19.